{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:47:08Z","timestamp":1791100028046,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/md.0b013e318190cfb7","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T03:09:55Z","timestamp":1226372995000},"page":"301-310","source":"Crossref","is-referenced-by-count":340,"title":["Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome"],"prefix":"10.1097","volume":"87","author":[{"given":"Jeroen C. H.","family":"van der Hilst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien J.","family":"Bodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyl S.","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210226","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R2-1-20210226","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2249.2002.02002.x","article-title":"Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.","volume":"130","author":"Arkwright","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R3-1-20210226","first-page":"24","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"key":"R4-1-20210226","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2005-10-039578","article-title":"Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.","volume":"109","author":"Bodar","year":"2007","journal-title":"Blood"},{"key":"R5-1-20210226","first-page":"355","article-title":"Quality of life of patients with familial Mediterranean fever.","volume":"15","author":"Buskila","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"R6-1-20210226","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0408-7","article-title":"Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.","volume":"29","author":"Cailliez","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R8-1-20210226","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"R9-1-20210226","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1010525206818","article-title":"Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D.","volume":"24","author":"Di Rocco","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R10-1-20210226","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.","volume":"46","author":"Dode","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"R12-1-20210226","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.157.1.400","article-title":"Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells.","volume":"157","author":"Drenth","year":"1996","journal-title":"J Immunol"},{"key":"R13-1-20210226","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"R14-1-20210226","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","article-title":"Hereditary periodic fever.","volume":"345","author":"Drenth","year":"2001","journal-title":"N Engl J Med"},{"key":"R15-1-20210226","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08870440108405502","article-title":"Health-related quality of life in young adults with minor congenital heart disease.","volume":"16","author":"Fekkes","year":"2001","journal-title":"Psychol Health"},{"key":"R16-1-20210226","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","article-title":"Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R17-1-20210226","first-page":"336","article-title":"Course of life questionnaire for young adults.","volume":"31","author":"Grootenhuis","year":"2003","journal-title":"Gedrag Gezondheid"},{"key":"R18-1-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome.","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"R19-1-20210226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"R20-1-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1388-1981(00)00135-9","article-title":"Biochemical and genetic aspects of mevalonate kinase and its deficiency.","volume":"1529","author":"Houten","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R21-1-20210226","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.2006.068841","article-title":"Autoinflammatory gene mutations in Behcet's disease.","volume":"66","author":"Kone-Paut","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R22-1-20210226","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.molimm.2007.12.008","article-title":"Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.","volume":"45","author":"Kuijk","year":"2008","journal-title":"Mol Immunol"},{"key":"R23-1-20210226","first-page":"1558","article-title":"Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features.","volume":"24","author":"Livneh","year":"1997","journal-title":"J Rheumatol"},{"key":"R24-1-20210226","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion.","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R25-1-20210226","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/humu.20361","article-title":"Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.","volume":"27","author":"Mandey","year":"2006","journal-title":"Hum Mutat"},{"key":"R26-1-20210226","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.ejhg.5200725","article-title":"Familial Mediterranean fever: association of elevated IgD plasma levels with specific MEFV mutations.","volume":"9","author":"Medlej-Hashim","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"R27-1-20210226","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","article-title":"First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome.","volume":"50","author":"Obici","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R28-1-20210226","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1545-5300.1992.00383.x","article-title":"Lives in a balance: perceived family functioning and the psychosocial adjustment of adolescent cancer survivors.","volume":"31","author":"Rait","year":"1992","journal-title":"Fam Process"},{"key":"R29-1-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(03)00212-9","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) in a child with normal serum IgD, but increased serum IgA concentration.","volume":"143","author":"Saulsbury","year":"2003","journal-title":"J Pediatr"},{"key":"R30-1-20210226","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.amjmed.2004.02.039","article-title":"Beneficial response to interleukin 1 receptor antagonist in TRAPS.","volume":"117","author":"Simon","year":"2004","journal-title":"Am J Med"},{"key":"R31-1-20210226","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R32-1-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pon.839","article-title":"The course of life of survivors of childhood cancer.","volume":"14","author":"Stam","year":"2005","journal-title":"Psychooncology"},{"key":"R33-1-20210226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jadohealth.2005.03.011","article-title":"Young adult patients with a history of pediatric disease: impact on course of life and transition into adulthood.","volume":"39","author":"Stam","year":"2006","journal-title":"J Adolesc Health"},{"key":"R34-1-20210226","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","article-title":"Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"48","author":"Takada","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R35-1-20210226","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/art.21408","article-title":"MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients.","volume":"52","author":"Tchernitchko","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R36-1-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000152370.84628.0c","article-title":"Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.","volume":"84","author":"Tunca","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R37-1-20210226","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","article-title":"Hereditary periodic fever and reactive amyloidosis.","volume":"5","author":"van der Hilst","year":"2005","journal-title":"Clin Exp Med"},{"key":"R39-1-20210226","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","article-title":"Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.","volume":"1","author":"van der Meer","year":"1984","journal-title":"Lancet"},{"key":"R40-1-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00435982","article-title":"A comparison of two multidimensional measures of health status: the Nottingham Health Profile and the RAND 36-Item Health Survey 1.0.","volume":"5","author":"VanderZee","year":"1996","journal-title":"Qual Life Res"},{"key":"R41-1-20210226","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1207\/s15327558ijbm0302_2","article-title":"Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status.","volume":"3","author":"VanderZee","year":"1996","journal-title":"Int J Behav Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e318190cfb7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:12:44Z","timestamp":1786036364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200811000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e318190cfb7","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}